Lucy Lu

2017 - AVENUE THERAPEUTICS

In 2017, Lucy Lu earned a total compensation of $2M as Chief Executive Officer at AVENUE THERAPEUTICS, a 490% increase compared to previous year.

Compensation breakdown

Bonus$282,625
Salary$294,940
Stock Awards$1,455,550
Total$2,033,115

Lu received $1.5M in stock awards, accounting for 72% of the total pay in 2017.

Lu also received $282.6K in bonus and $294.9K in salary.

Rankings

In 2017, Lucy Lu's compensation ranked 5,416th out of 14,666 executives tracked by ExecPay. In other words, Lu earned more than 63.1% of executives.

ClassificationRankingPercentile
All
5,416
out of 14,666
63rd
Division
Manufacturing
1,943
out of 5,768
66th
Major group
Chemicals And Allied Products
582
out of 2,074
72nd
Industry group
Drugs
447
out of 1,730
74th
Industry
Pharmaceutical Preparations
352
out of 1,329
74th
Source: SEC filing on April 30, 2018.

Lu's colleagues

We found two more compensation records of executives who worked with Lucy Lu at AVENUE THERAPEUTICS in 2017.

2017

Joseph Vazzano

AVENUE THERAPEUTICS

Vice President of Finance and Corporate Controller

2017

Scott Reines

AVENUE THERAPEUTICS

Chief Medical Officer

News

You may also like